Fibrous Dysplasia: An Epidemiological and Correlational Study of Anthropometric, Clinical, Treatment, and Genetic Data
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-12
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
Brief Title
Who Can Participate
AI-Screening
Your Study Journey
Trial Site Locations
Research Team
How is the study designed?
Similar Trials
Frequently Asked Questions
Research Publications
AI-Summary
What this Trial Is About
Fibrous dysplasia is a non-hereditary genetic condition characterized by areas of abnormal bone development where normal bone is replaced by fibrous tissue. This condition can vary widely in presentation, occurring as monostotic, polyostotic, or panostotic forms, and may be part of complex syndromes like McCune-Albright syndrome or Mazabraud syndrome. The condition arises from mutations in the GNAS gene, leading to a genetic mosaic state in affected individuals. This research aims to provide a detailed evaluation of patient characteristics, hospitalizations, and interventions, with a study group of over 200 patients to offer a comprehensive understanding of the condition and its genetic impacts.
The study is observational and includes patients with fibrous dysplasia, McCune-Albright syndrome, and Mazabraud syndrome who have available clinical, radiological, surgical, and tissue biospecimen data. Two main patient groups are studied: those with clinical and surgical data and those with available tissue samples for molecular analysis. This approach allows for a broad assessment of the clinical features and genetic correlations related to these conditions.
Participants' involvement includes the collection and analysis of clinical and radiological data, surgical procedure descriptions, and molecular studies of tissue samples. Researchers monitor surgical procedures, clinical features, genotype-phenotype correlations, post-intervention complications, and pain over four years. This detailed data collection aims to improve understanding of the disease's manifestations and outcomes, with ongoing observation throughout the study period.
CONDITIONS
Brief Title
Fibrous Dysplasia: An Epidemiological and Correlational Evaluation of Multimodal Data
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
Patients affected by Fibrous Dysplasia, McCune-Albright syndrome, or Mazabraud syndrome, including those retrospectively included since 2009
Availability of clinical and radiological data collected during recovery at the Istituto Ortopedico Rizzoli
Availability of tumor tissue in the biobank in sufficient quantity and quality
You will not qualify if you...
Patients who do not meet the inclusion criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Up to 4 years
Participants undergo evaluation of clinical, radiological, and surgical data related to Fibrous Dysplasia and related syndromes.
Visits as needed for data collection during the study period
Long-term Monitoring
Duration - Up to 4 years
Participants with available tissue samples are observed for molecular investigations and genotype-phenotype correlations.